Question 1

Am I eligible to continue with Ixabepilone based on my current health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline clinical trial (NCT01027208). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of continuing Ixabepilone therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline clinical trial (NCT01027208). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options I may have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline clinical trial (NCT01027208). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I expect during the treatment process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline clinical trial (NCT01027208). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to come in for treatment or check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline clinical trial (NCT01027208). Contact the study team or your healthcare provider for specific answers.

What this study is about